Profile of Idiopathic Pulmonary Fibrosis Cases at a Tertiary Care Institute

  • Dr Nitin Khantal Assistant professor, Department of Radiology, Chirayu Medical College and Hospital, Bhopal, India
  • Dr Ashish Dubey Assistant professor, Department of Tb & chest, Chirayu Medical College and Hospital, Bhopal, MP, India
Keywords: Age, Lung biopsy, Fibrosing alveolitis, High resolution computed tomography

Abstract

Objective: Idiopathic pulmonary fibrosis is characterized by acute or chronic diffuse involvement of pulmonary parenchyma leading to a variable degree of lung fibrosis. Study was planned to asses clinical profile of patients with idiopathic pulmonary fibrosis (IPF) and methods used for diagnosis.

Material and methods: It was a retrospective analysis of symptoms, signs, radiological findings and lung biopsy of patients diagnosed to have IPF over a 16-month period.

Results: During the study period, 185 patients (85 men) with a mean age of 44.63 ± 10.4 years were diagnosed to have IPF. Breathlessness (100%) and dry cough (53.4%) were the most common presenting symptoms. Patients were diagnosed based on clinical features and high resolution chest tomography (HRCT) findings. HRCT was performed in all patients; 90% had features suggestive of diffuse interstitial fibrosis. Transbronchial lung biopsy (TBLB) was performed in 20 (10%) patients.

Conclusion: IPF is diagnosed more commonly now than in the past. Indian patients may be developing the disease a decade earlier than their counterparts in the West. TBLB and HRCT are useful in establishing diagnosis. IPF should be considered a distinct clinical entity rather than a diagnosis of exclusion.

Downloads

Download data is not yet available.

References

1. Raghu G. Interstitial lung disease. In: Goldman L, Schafer AI, editors Cecil Medicine; 24th editon. Philadelphia: W.B. Saunders;2011: 556-66.

2. Anthony Seaton. Pulmonary fibrosis. In: Crofton & Douglas’s respiratory diseases. 5th edition: 877-892.

3. American Thoracic Society Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am. J. Respir. Crit. Care Med. 2000; 161: 646–664.

4. López-Campos JL1, Rodríguez-Becerra E; Neumosur Task Group; Registry of Interstitial Lung Diseases. Incidence of interstitial lung diseases in the south of Spain 1998–2000: the RENIA study. Eur J Epidemiol. 2004;19(2):155-61.

5. Coultas DB1, Zumwalt RE, Black WC, Sobonya RE. The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med. 1994 Oct;150(4):967-72. [PubMed]

6. Jindal SK, Malik SK, Deodhar SD, Sharma BK. Fibrosing alveolitis: a report of 61 cases seen over the past five years. Indian J Chest Dis Allied Sci. 1979 Oct-Dec;21(4):174-9. [PubMed]

7. Sharma SK, Pande JN, Guleria JS. Diffuse interstitial pulmonary fibrosis. Indian J Chest Dis Allied Sci. 1984 Oct-Dec;26(4):214-9. [PubMed]

8. The American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am. J. Res. Crit. care Med. 2002; 165: 277–304.

9. American Thoracic Society, European Respiratory Society, World Association of sarcoidosis and Other Granulomatous Disorders. Statement on sarcoidosis. Am. J. Respir. Crit. Care Med. 1999; 160: 736-55.

10. Kornum JB, Christensen S, Grijota M, Pedersen L, Wogelius P, Beiderbeck A, Sørensen HT. The incidence of interstitial lung disease 1995–2005: a Danish nationwide population-based studyBMC Pulm Med. 2008 Nov 4;8:24. doi: 10.1186/1471-2466-8-24.

11. Louw SJ, Bateman ED, Benatar SR. Cryptogenic fibrosing alveolitis : Clinical spectrum and treatment. South Afr Med J 1984; 65 : 195-200. [PubMed]

12. Smith C, Feldman C, Levy H, Kallenbach JM, Zwi S. Cryptogenic fibrosing alveolitis : A study of an indigenous African population. Respiration. 1990;57(6):364-71. [PubMed]

13. Johnston ID, Prescott RJ, Chalmers JC, Rudd RM. British Thoracic Society study of cryptogenic fibrosing alveolitis : Current presentation and initial management. Thorax. 1997 Jan;52(1):38-44. [PubMed]

14. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 1):646-64. [PubMed]

15. British Thoracic Society. The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults :Introduction. Thorax. 1999 Apr;54 Suppl 1:S1-14. [PubMed]

16. Grenier P, Valeyre D, Cluzel P, Brauner MW, Lenoir S, Chastang C. Chronic diffuse interstitial lung disease. Diagnostic value of chest radiography and high resolution CT. Radiology. 1991 Apr;179(1):123-32.
CITATION
DOI: 10.17511/ijmrr.2015.i7.135
Published: 2015-08-31
How to Cite
1.
Khantal N, Dubey A. Profile of Idiopathic Pulmonary Fibrosis Cases at a Tertiary Care Institute. Int J Med Res Rev [Internet]. 2015Aug.31 [cited 2024Nov.22];3(7):717-20. Available from: https://ijmrr.medresearch.in/index.php/ijmrr/article/view/308
Section
Original Article